|
RBM16 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.25970000886389E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.56030000031393E-09 |
| Normal-vs-Stage2 |
1.004670E-04 |
| Normal-vs-Stage3 |
7.037300E-03 |
| Normal-vs-Stage4 |
3.076300E-03 |
| Stage1-vs-Stage2 |
6.796600E-01 |
| Stage1-vs-Stage3 |
1.959770E-01 |
| Stage1-vs-Stage4 |
6.223600E-01 |
| Stage2-vs-Stage3 |
5.216200E-01 |
| Stage2-vs-Stage4 |
8.461800E-01 |
| Stage3-vs-Stage4 |
7.489600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.17559997689665E-09 |
| Normal-vs-AfricanAmerican |
2.42839999997635E-06 |
| Normal-vs-Asian |
2.043200E-04 |
| Caucasian-vs-AfricanAmerican |
6.176400E-01 |
| Caucasian-vs-Asian |
3.278000E-01 |
| AfricanAmerican-vs-Asian |
4.935800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.22889945284055E-10 |
| Normal-vs-Female |
9.755600E-04 |
| Male-vs-Female |
2.656000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.55699999999648E-05 |
| Normal-vs-Extreme_Weight |
3.1341995665457E-10 |
| Normal-vs-Obese |
7.62930000000051E-05 |
| Normal-vs-Extreme_Obese |
3.08869999998684E-06 |
| Normal_Weight-vs-Extreme_Weight |
3.315200E-01 |
| Normal_Weight-vs-Obese |
3.190800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.044600E-01 |
| Extreme_Weight-vs-Obese |
2.473800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.676600E-01 |
| Obese-vs-Extreme_Obese |
1.386590E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.709900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.81230999999338E-05 |
| Normal-vs-Age(61-80Yrs) |
1.31250010859674E-10 |
| Normal-vs-Age(81-100Yrs) |
5.22109999678833E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.332400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.294200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.811640E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.344200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.713700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.671200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.03599999690118E-08 |
| Normal-VS-Type2 PRCC |
5.12480002878846E-09 |
| Normal-VS-KIRP CIMP |
2.492400E-01 |
| Normal-VS-Unclassified PRCC |
2.936000E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.767000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.921600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.929600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.372200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.380960E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.253800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.23320242906289E-11 |
| Normal-vs-N1 |
2.762200E-01 |
| Normal-vs-N2 |
1.59382999999069E-05 |
| N0-vs-N1 |
9.427300E-04 |
| N0-vs-N2 |
1.570090E-02 |
| N1-vs-N2 |
1.97618999999705E-05 |
|
|
